= PDF Reprint, = BibTeX entry, = Online Abstract
E. Itti, G. Villafane, Z. Malek, P. Brugieres, D. Capacchione, L. Itti, P. Maison, P. Cesaro, M. Meignan, Dopamine transporter imaging under high-dose transdermal nicotine therapy in Parkinson's disease: an observational study, Nuclear Medicine Communications, Vol. 30, No. 7, pp. 513-518, Jul 2009. [2008 impact factor: 1.706]
Abstract: OBJECTIVES: Nicotine therapy might improve the course of Parkinson's disease. This observational study evaluated the performance of dopamine transporter imaging in follow-up patients under nicotine therapy. METHODS: Six Hoehn and Yahr stage III patients underwent 123I-FP-CIT imaging prior to, 3 months, and 1 year after the onset of nicotine therapy. Nicotine was administered transdermally with increasing daily doses during 3 months (up to 105 mg/day) and decreased progressively. On co-registered magnetic resonance imaging, striatal regions of interest were drawn and binding potentials of 123I-FP-CIT were calculated.Changes in Unified Parkinson's Disease Rating Scale-III over time were compared with binding potentials using regression analysis. RESULTS: All patients improved motor scores at 3 months (-65 +/- 22% 'off', -89 +/- 12% 'on') and most received fewer dopaminergic drugs (-30% dosage in average). Motor improvement persisted to a lesser extent at 1 year(-39 +/- 31% 'off', -13 +/- 43% 'on'), partly because one patient stopped the treatment. Interestingly, the decrease in binding potentials (-4.0 +/- 10.5%) was slower than that expected in Parkinsonian patients (usually -10% per year) and was inversely correlated with Unified Parkinson's Disease Rating Scale-III improvement, r= 0.83 'off' and 0.91 'on'. CONCLUSION: This observational study emphasizes a potential effect of nicotine therapy on striatal dopamine transporter density, which may be interpreted as direct pharmacological effect or deceleration of neuronal loss.
Themes: Medical Research, Medical Image Processing
Copyright © 2000-2007 by the University of Southern California, iLab and Prof. Laurent Itti.
This page generated by bibTOhtml on Tue 10 Jan 2023 02:30:30 PM PST